Watany, M. M., Elhosary, M. M., El-Horany, H. E., & El-Horany, M. E. (2024). Methylation of Interleukin-1 receptor-associated kinase-3 and the risk of multiple sclerosis relapse/activity. Clinical immunology (Orlando, Fla.), 266, 110327. https://doi.org/10.1016/j.clim.2024.110327
Chicago ZitierstilWatany, Mona M., Marwa M. Elhosary, Hemat E. El-Horany, und Mahmoud E. El-Horany. "Methylation of Interleukin-1 Receptor-associated Kinase-3 and the Risk of Multiple Sclerosis Relapse/activity." Clinical Immunology (Orlando, Fla.) 266 (2024): 110327. https://dx.doi.org/10.1016/j.clim.2024.110327.
MLA ZitierstilWatany, Mona M., et al. "Methylation of Interleukin-1 Receptor-associated Kinase-3 and the Risk of Multiple Sclerosis Relapse/activity." Clinical Immunology (Orlando, Fla.), vol. 266, 2024, p. 110327.